CH435261A - Verfahren zur Herstellung neuer 19-Nor-androstene - Google Patents

Verfahren zur Herstellung neuer 19-Nor-androstene

Info

Publication number
CH435261A
CH435261A CH93363A CH93363A CH435261A CH 435261 A CH435261 A CH 435261A CH 93363 A CH93363 A CH 93363A CH 93363 A CH93363 A CH 93363A CH 435261 A CH435261 A CH 435261A
Authority
CH
Switzerland
Prior art keywords
androstenes
new
production
Prior art date
Application number
CH93363A
Other languages
English (en)
Inventor
Wettstein Albert Dr Prof
Georg Dr Anner
Peter Dr Wieland
Karl Dr Heusler
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1377562A external-priority patent/CH451930A/de
Application filed by Ciba Geigy filed Critical Ciba Geigy
Priority to SE12879/63A priority Critical patent/SE319471B/xx
Priority to FR963624A priority patent/FR3174M/fr
Publication of CH435261A publication Critical patent/CH435261A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
CH93363A 1962-11-23 1963-01-25 Verfahren zur Herstellung neuer 19-Nor-androstene CH435261A (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE12879/63A SE319471B (de) 1962-11-23 1963-11-21
FR963624A FR3174M (fr) 1962-11-23 1964-02-13 Nouvel δ-3β17β-dihydroxy-7α17α-diméthyl-19-nor-androstene utilisable en thérapie.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1377562A CH451930A (de) 1962-11-23 1962-11-23 Verfahren zur Herstellung neuer Methylöstrene
CH792363 1963-06-26

Publications (1)

Publication Number Publication Date
CH435261A true CH435261A (de) 1967-05-15

Family

ID=25702457

Family Applications (1)

Application Number Title Priority Date Filing Date
CH93363A CH435261A (de) 1962-11-23 1963-01-25 Verfahren zur Herstellung neuer 19-Nor-androstene

Country Status (6)

Country Link
US (1) US3301879A (de)
BE (1) BE640298A (de)
BR (2) BR6354771D0 (de)
CH (1) CH435261A (de)
DE (1) DE1250819B (de)
GB (1) GB1060828A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413287A (en) * 1966-05-02 1968-11-26 Searle & Co (optionally 17-alkylated) 7alpha-methylan-drostone-3beta, 17beta-diols, delta4 and 19-nor derivatives corresponding and ethers and esters thereof
US3412112A (en) * 1966-10-12 1968-11-19 American Home Prod 3beta, 10alpha-17beta-triol-gon-4-enes and derivatives thereof
US3658854A (en) * 1969-04-16 1972-04-25 Syntex Corp 3-alkoxymethylenoxy ethers of androstanes and 19-norandrostanes and their preparation
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3068249A (en) * 1960-12-15 1962-12-11 Searle & Co Alkyl ethers of 17-(hydrocarbon-substituted)estr-4-ene-3, 17-diols
US3176013A (en) * 1963-07-25 1965-03-30 Searle & Co 17alpha-(aliphatic hydrocarbon)-4, 5-epoxy-19-norandrostane-3beta, 17beta-diols and lower alkanoates thereof

Also Published As

Publication number Publication date
BR6354771D0 (pt) 1973-07-12
BR6354776D0 (pt) 1973-07-12
DE1250819B (de) 1967-09-28
GB1060828A (en) 1967-03-08
US3301879A (en) 1967-01-31
BE640298A (de)

Similar Documents

Publication Publication Date Title
CH480330A (de) Verfahren zur Herstellung neuer Benzodioxan-Derivate
CH415632A (de) Verfahren zur Herstellung neuer 3-Pyrrolidylmethylamine
AT257556B (de) Verfahren zur Herstellung von Alkoholen
CH485746A (de) Verfahren zur Herstellung neuer Benzo-azacycloalkene
CH435261A (de) Verfahren zur Herstellung neuer 19-Nor-androstene
CH432538A (de) Verfahren zur Herstellung neuer Yohimban-Derivate
CH437278A (de) Verfahren zur Herstellung neuer Oestranderivate
CH405292A (de) Verfahren zur Herstellung neuer Homo-Steroide
CH407970A (de) Verfahren zur Herstellung neuer Telomerisate
AT248032B (de) Verfahren zur Herstellung neuer 3α-Phenyl-granatan-Derivate
AT242864B (de) Verfahren zur Herstellung neuer Acylamino-cephalosporansäuren
CH442294A (de) Verfahren zur Herstellung neuer 7a-Methyl-androstene
CH448049A (de) Verfahren zur Herstellung neuer Benzolsulfonylsemicarbazide
CH433359A (de) Verfahren zur Herstellung neuer 3a-Phenyl-granatan-Derivate
AT248694B (de) Verfahren zur Herstellung neuer Telomerisate
CH440264A (de) Verfahren zur Herstellung neuer B-Homo-steroiden
AT241698B (de) Verfahren zur Herstellung neuer 3-Phenyl-granaten-(2)-Derivate
AT241645B (de) Verfahren zur Herstellung neuer komplexer Bleiverbindungen
CH407072A (de) Verfahren zur Herstellung neuer Telomerisate
CH439308A (de) Verfahren zur Herstellung neuer Phthalazinium-Verbindungen
CH433360A (de) Verfahren zur Herstellung neuer 3ss-Phenyl-granatan-Derivate
AT258482B (de) Verfahren zur Herstellung neuer 6-Methyl- und 1,6-Dimethyl-8-amino-methyl-ergolin-I-derivate
AT253130B (de) Verfahren zur Herstellung neuer Nukleoside
CH443277A (de) Verfahren zur Herstellung neuer Phenylcyclohexylalkamine
CH481083A (de) Verfahren zur Herstellung neuer 4-Halogen-androstene